These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 17229591)
1. Schistosomiasis and malaria: another piece of the crossreactivity puzzle. Helmby H Trends Parasitol; 2007 Mar; 23(3):88-90. PubMed ID: 17229591 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Pierrot C; Wilson S; Lallet H; Lafitte S; Jones FM; Daher W; Capron M; Dunne DW; Khalife J Infect Immun; 2006 Jun; 74(6):3347-54. PubMed ID: 16714563 [TBL] [Abstract][Full Text] [Related]
10. Apical membrane antigen 1: a malaria vaccine candidate in review. Remarque EJ; Faber BW; Kocken CH; Thomas AW Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584 [TBL] [Abstract][Full Text] [Related]
11. High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar. Lee HW; Moon SU; Kim YJ; Cho SH; Lin K; Na BK; Kim TS Korean J Parasitol; 2008 Sep; 46(3):195-8. PubMed ID: 18830063 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against some zoonotic parasites in commensal rodents trapped from Dakahlia Governorate, Egypt. el-Shazly AM; Romia SA; el Ganayni GA; Abou-Zakham AA; Sabry AH; Morsy TA J Egypt Soc Parasitol; 1991 Apr; 21(1):169-77. PubMed ID: 2033290 [TBL] [Abstract][Full Text] [Related]
13. Responses to malarial antigens are altered in helminth-infected children. Hartgers FC; Obeng BB; Kruize YC; Dijkhuis A; McCall M; Sauerwein RW; Luty AJ; Boakye DA; Yazdanbakhsh M J Infect Dis; 2009 May; 199(10):1528-35. PubMed ID: 19392626 [TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R; Tallima H Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in vaccine research against schistosomiasis in Brazil. Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363 [TBL] [Abstract][Full Text] [Related]
16. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Tendler M; Simpson AJ Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134 [TBL] [Abstract][Full Text] [Related]
18. The schistosoma-specific antibody response after treatment in non-immune travellers. Duus LM; Christensen AV; Navntoft D; Tarp B; Nielsen HV; Petersen E Scand J Infect Dis; 2009; 41(4):285-90. PubMed ID: 19221932 [TBL] [Abstract][Full Text] [Related]
19. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. Oleinikov AV; Rossnagle E; Francis S; Mutabingwa TK; Fried M; Duffy PE J Infect Dis; 2007 Jul; 196(1):155-64. PubMed ID: 17538896 [TBL] [Abstract][Full Text] [Related]
20. Application of dipstick dye immunoassay (DDIA) kit for the diagnosis of schistosomiasis mekongi. Zhu YC; Socheat D; Bounlu K; Liang YS; Sinuon M; Insisiengmay S; He W; Xu M; Shi WZ; Bergquist R Acta Trop; 2005; 96(2-3):137-41. PubMed ID: 16143289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]